跳至主要内容
临床试验/NCT07472192
NCT07472192招募中2 期

Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With Polydeoxyribonucleotide (PDRN) Versus Fractional CO₂ Laser: A Randomized Controlled Clinical Study

Misr University for Science and Technology1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年3月1日最近更新:
干预措施

试验速览

阶段
2 期
状态
招募中
入组人数
36
试验地点
1
主要终点
Vancouver Scar Scale

研究概览

简要总结

Facial scars are frequently deemed unpleasant and can profoundly impact a patient's psychological health. This study compares the effectiveness, safety, and capacity to speed up scar healing in the maxillofacial region between fractional carbon dioxide (CO₂) laser therapy alone and polydeoxyribonucleotide (PDRN) combined with CO₂ laser therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Masking Description

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age Limitations: Participants must be between 18 and 50 years of age.
  • Recently cut wounds or surgical scars from about (1-6 months).
  • Consent to Participate: Willingness to provide informed consent and engage in all aspects of the study.

排除标准

  • Pregnancy or breastfeeding at the time of study.
  • Known allergy to PDRN.
  • Medication use that could affect wound healing or inflammation, such as:
  • Isotretinoin.
  • Anticancer drugs.
  • High-dose corticosteroids.
  • Anticoagulants.
  • Uncontrolled medical diseases (e.g., unstable diabetes, cardiac conditions).

研究组 & 干预措施

Fractional Carbon Dioxide Laser Combined with Polydeoxyribonucleotide (PDRN)

Active Comparator

includes patients who will be enrolled for PDRN injection into the surgical scar

干预措施: Polydeoxyribonucleotide (Drug)

Fractional Carbon Dioxide Laser Combined with Polydeoxyribonucleotide (PDRN)

Active Comparator

includes patients who will be enrolled for PDRN injection into the surgical scar

干预措施: Fractional CO2 laser assisted PDT (Device)

Fractional CO₂ laser therapy with placebo saline injection

Placebo Comparator

includes patients who will be enrolled for placebo saline injection into the surgical scar

干预措施: Fractional CO2 laser assisted PDT (Device)

结局指标

主要结局

Vancouver Scar Scale

时间窗: 4 months

The study used the standard Vancouver Scar Scale, which evaluates four characteristics of scars: Total Score Range: 0 (normal skin) to 13 (severe hypertrophic scar)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omnia Tarek Hosni

Demonstrator in Oral & Maxillofacial Surgery Department, MUST

Misr University for Science and Technology

研究点 (1)

Loading locations...

相似试验